We are live on ! Find out more
GC

Globeflex Capital Portfolio holdings

AUM $661M
1-Year Est. Return 50.59%
This Fund
S&P 500
This Quarter Est. Return
+3.96%
1 Year Est. Return
+50.59%
3 Year Est. Return
+135.47%
5 Year Est. Return
+202.82%
10 Year Est. Return
+1,069.65%
AUM
$1.18B
AUM Growth
+$135M
Cap. Flow
+$141M
Cap. Flow %
11.99%
Top 10 Hldgs %
28.51%
Holding
522
New
58
Increased
52
Reduced
58
Closed
93

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$33.6M
2
GOOG icon
Alphabet (Google) Class C
GOOG
+$32.7M
3
V icon
Visa
V
+$30.2M
4
EXEL icon
Exelixis
EXEL
+$21.2M
5
TT icon
Trane Technologies
TT
+$20.6M

Top Sells

Rank Stock Value
1
HOLX
Hologic
HOLX
+$6.85M
2
CCEP icon
Coca-Cola Europacific Partners
CCEP
+$6.7M
3
ARW icon
Arrow Electronics
ARW
+$6.63M
4
YPF icon
YPF
YPF
+$6.31M
5
SNPS icon
Synopsys
SNPS
+$6.28M

Sector Composition

Rank Sector Weight
1 Technology 23.9%
2 Healthcare 21.38%
3 Financials 15.14%
4 Consumer Discretionary 14.1%
5 Industrials 12.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CTLP
76
DELISTED
Cantaloupe
CTLP
$3.87M 0.33%
406,804
NTB icon
77
Bank of N.T. Butterfield & Son
NTB
$2.43B
$3.84M 0.33%
105,050
GLOB icon
78
Globant
GLOB
$1.58B
$3.82M 0.32%
17,809
EPAM icon
79
EPAM Systems
EPAM
$5.51B
$3.72M 0.32%
+15,900
New +$3.54M
GAP
80
The Gap Inc
GAP
$7.23B
$3.63M 0.31%
153,542
TILE icon
81
Interface
TILE
$1.99B
$3.59M 0.3%
147,621
RDVT icon
82
Red Violet
RDVT
$979M
$3.56M 0.3%
98,231
+10,587
+12% +$353K
RNG icon
83
RingCentral
RNG
$4.66B
$3.47M 0.29%
99,107
PLYA
84
DELISTED
Playa Hotels & Resorts
PLYA
$3.42M 0.29%
270,639
SFM icon
85
Sprouts Farmers Market
SFM
$8.13B
$3.4M 0.29%
26,750
-2,759
-9% -$367K
NBN icon
86
Northeast Bank
NBN
$1.06B
$3.24M 0.27%
35,339
NBIX icon
87
Neurocrine Biosciences
NBIX
$16.8B
$3.19M 0.27%
23,404
+1,202
+5% +$149K
ALSN icon
88
Allison Transmission
ALSN
$9.5B
$3.15M 0.27%
29,177
CSR
89
Centerspace
CSR
$921M
$3.15M 0.27%
47,563
PLYM
90
DELISTED
Plymouth Industrial REIT
PLYM
$3.14M 0.27%
176,482
+44,680
+34% +$883K
AMAL icon
91
Amalgamated Financial
AMAL
$1.48B
$3.12M 0.26%
93,152
BXC icon
92
BlueLinx
BXC
$422M
$3.12M 0.26%
30,511
MKSI icon
93
MKS Inc
MKSI
$20.1B
$2.99M 0.25%
28,638
+3,367
+13% +$363K
MORN icon
94
Morningstar
MORN
$7.22B
$2.98M 0.25%
8,835
PNTG icon
95
Pennant Group
PNTG
$1.4B
$2.97M 0.25%
111,813
HSTM icon
96
HealthStream
HSTM
$819M
$2.92M 0.25%
91,972
TRV icon
97
Travelers Companies
TRV
$78.1B
$2.89M 0.25%
+12,000
New +$3M
OUT icon
98
Outfront Media
OUT
$5.61B
$2.84M 0.24%
156,179
+60,359
+63% +$1.12M
ACEL icon
99
Accel Entertainment
ACEL
$978M
$2.81M 0.24%
263,183
+12,789
+5% +$146K
RSI icon
100
Rush Street Interactive
RSI
$2.77B
$2.79M 0.24%
+203,141
New +$2.47M

Similar funds

Globeflex Capital's Q4 2024 Portfolio in Review

As of Q4 2024, Globeflex Capital held 522 positions worth $1.18B, up 13% from $1.04B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Globeflex Capital deployed $141M of net new capital in Q4 2024, opening 58 new positions and adding to 52 existing holdings. Its largest new stake was Bristol-Myers Squibb: 602,224 shares worth $34.1M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 25% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Arrow Electronics, an estimated $6.63M trimmed.

  • Globeflex Capital's largest Q4 2024 buy was Bristol-Myers Squibb: 602,224 shares worth $34.1M.
  • Globeflex Capital added most to Alphabet (Google) Class C in Q4 2024, an estimated $32.7M increase.
  • Globeflex Capital's biggest Q4 2024 reduction was Arrow Electronics, cutting an estimated $6.63M.
  • Globeflex Capital fully exited Hologic in Q4 2024, selling an estimated $6.85M.
  • Globeflex Capital's ten largest holdings make up 29% of its $1.18B portfolio in Q4 2024.
  • Globeflex Capital opened 58 new positions and closed 93 in Q4 2024.
  • Globeflex Capital's portfolio value rose 13% quarter-over-quarter to $1.18B.

Based on Globeflex Capital's 13F filing for Q4 2024, filed 10 Feb 2025.